Cargando…
Engineering protein glycosylation in CHO cells to be highly similar to murine host cells
Since 2015 more than 34 biosimilars have been approved by the FDA. This new era of biosimilar competition has stimulated renewed technology development focused on therapeutic protein or biologic manufacturing. One challenge in biosimilar development is the genetic differences in the host cell lines...
Autores principales: | Gupta, Shivani, Shah, Bhavana, Fung, Coral Shek, Chan, Pik Kay, Wakefield, Devin L., Kuhns, Scott, Goudar, Chetan T., Piret, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978007/ https://www.ncbi.nlm.nih.gov/pubmed/36873370 http://dx.doi.org/10.3389/fbioe.2023.1113994 |
Ejemplares similares
-
Decoupling Growth and Protein Production in CHO Cells: A Targeted Approach
por: Donaldson, James S., et al.
Publicado: (2021) -
Enhanced Transgene Expression by Optimization of Poly A in Transfected CHO Cells
por: Wang, Xiao-yin, et al.
Publicado: (2022) -
The Effect of microRNA on the Production of Recombinant Protein in CHO Cells and its Mechanism
por: Liu, Hui-Ning, et al.
Publicado: (2022) -
Stabilizing and Anti-Repressor Elements Effectively Increases Transgene Expression in Transfected CHO Cells
por: Li, Qin, et al.
Publicado: (2022) -
Functional Trimeric SARS-CoV-2 Envelope Protein Expressed in Stable CHO Cells
por: Mayrhofer, Patrick, et al.
Publicado: (2021)